English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 129 | Tables: 241 | Pharma & Healthcare
Vaccines administered nasally
The global market for Intranasal Vaccine was estimated to be worth US$ 565 million in 2023 and is forecast to a readjusted size of US$ 797.4 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intranasal Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Intranasal Vaccine by region & country, by Type, and by Application.
The Intranasal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intranasal Vaccine.
Market Segmentation
By Company
Sanofi
AstraZeneca
Abbott
GlaxoSmithKline
Serum Institute of India
Bharat Biotech
Antares Pharma
INJEX Pharma GmbH
BioDiem
PharmaJet and Crossject
Beijing Wantai Biopharmaceutical Co., Ltd.
Changchun Baike Company
Segment by Type:
Flu Vaccine
COVID-19 Vaccines
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Intranasal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Intranasal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Intranasal Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Intranasal Vaccine Product Introduction
1.2 Global Intranasal Vaccine Market Size Forecast
1.2.1 Global Intranasal Vaccine Sales Value (2019-2030)
1.2.2 Global Intranasal Vaccine Sales Volume (2019-2030)
1.2.3 Global Intranasal Vaccine Sales Price (2019-2030)
1.3 Intranasal Vaccine Market Trends & Drivers
1.3.1 Intranasal Vaccine Industry Trends
1.3.2 Intranasal Vaccine Market Drivers & Opportunity
1.3.3 Intranasal Vaccine Market Challenges
1.3.4 Intranasal Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Intranasal Vaccine Players Revenue Ranking (2023)
2.2 Global Intranasal Vaccine Revenue by Company (2019-2024)
2.3 Global Intranasal Vaccine Players Sales Volume Ranking (2023)
2.4 Global Intranasal Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Intranasal Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Intranasal Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Intranasal Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Intranasal Vaccine
2.9 Intranasal Vaccine Market Competitive Analysis
2.9.1 Intranasal Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Intranasal Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Flu Vaccine
3.1.2 COVID-19 Vaccines
3.2 Global Intranasal Vaccine Sales Value by Type
3.2.1 Global Intranasal Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Intranasal Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Intranasal Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Intranasal Vaccine Sales Volume by Type
3.3.1 Global Intranasal Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Intranasal Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Intranasal Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Intranasal Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Intranasal Vaccine Sales Value by Application
4.2.1 Global Intranasal Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Intranasal Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Intranasal Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Intranasal Vaccine Sales Volume by Application
4.3.1 Global Intranasal Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Intranasal Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Intranasal Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Intranasal Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Intranasal Vaccine Sales Value by Region
5.1.1 Global Intranasal Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Intranasal Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Intranasal Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Intranasal Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Intranasal Vaccine Sales Volume by Region
5.2.1 Global Intranasal Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Intranasal Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Intranasal Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Intranasal Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Intranasal Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Intranasal Vaccine Sales Value, 2019-2030
5.4.2 North America Intranasal Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Intranasal Vaccine Sales Value, 2019-2030
5.5.2 Europe Intranasal Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Intranasal Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Intranasal Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Intranasal Vaccine Sales Value, 2019-2030
5.7.2 South America Intranasal Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Intranasal Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Intranasal Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Intranasal Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Intranasal Vaccine Sales Value
6.2.1 Key Countries/Regions Intranasal Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Intranasal Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Intranasal Vaccine Sales Value, 2019-2030
6.3.2 United States Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Intranasal Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Intranasal Vaccine Sales Value, 2019-2030
6.4.2 Europe Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Intranasal Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Intranasal Vaccine Sales Value, 2019-2030
6.5.2 China Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Intranasal Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Intranasal Vaccine Sales Value, 2019-2030
6.6.2 Japan Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Intranasal Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Intranasal Vaccine Sales Value, 2019-2030
6.7.2 South Korea Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Intranasal Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Intranasal Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Intranasal Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Intranasal Vaccine Sales Value, 2019-2030
6.9.2 India Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Intranasal Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Company Information
7.1.2 Sanofi Introduction and Business Overview
7.1.3 Sanofi Intranasal Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi Intranasal Vaccine Product Offerings
7.1.5 Sanofi Recent Development
7.2 AstraZeneca
7.2.1 AstraZeneca Company Information
7.2.2 AstraZeneca Introduction and Business Overview
7.2.3 AstraZeneca Intranasal Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 AstraZeneca Intranasal Vaccine Product Offerings
7.2.5 AstraZeneca Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Intranasal Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Abbott Intranasal Vaccine Product Offerings
7.3.5 Abbott Recent Development
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Information
7.4.2 GlaxoSmithKline Introduction and Business Overview
7.4.3 GlaxoSmithKline Intranasal Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 GlaxoSmithKline Intranasal Vaccine Product Offerings
7.4.5 GlaxoSmithKline Recent Development
7.5 Serum Institute of India
7.5.1 Serum Institute of India Company Information
7.5.2 Serum Institute of India Introduction and Business Overview
7.5.3 Serum Institute of India Intranasal Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Serum Institute of India Intranasal Vaccine Product Offerings
7.5.5 Serum Institute of India Recent Development
7.6 Bharat Biotech
7.6.1 Bharat Biotech Company Information
7.6.2 Bharat Biotech Introduction and Business Overview
7.6.3 Bharat Biotech Intranasal Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bharat Biotech Intranasal Vaccine Product Offerings
7.6.5 Bharat Biotech Recent Development
7.7 Antares Pharma
7.7.1 Antares Pharma Company Information
7.7.2 Antares Pharma Introduction and Business Overview
7.7.3 Antares Pharma Intranasal Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Antares Pharma Intranasal Vaccine Product Offerings
7.7.5 Antares Pharma Recent Development
7.8 INJEX Pharma GmbH
7.8.1 INJEX Pharma GmbH Company Information
7.8.2 INJEX Pharma GmbH Introduction and Business Overview
7.8.3 INJEX Pharma GmbH Intranasal Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 INJEX Pharma GmbH Intranasal Vaccine Product Offerings
7.8.5 INJEX Pharma GmbH Recent Development
7.9 BioDiem
7.9.1 BioDiem Company Information
7.9.2 BioDiem Introduction and Business Overview
7.9.3 BioDiem Intranasal Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 BioDiem Intranasal Vaccine Product Offerings
7.9.5 BioDiem Recent Development
7.10 PharmaJet and Crossject
7.10.1 PharmaJet and Crossject Company Information
7.10.2 PharmaJet and Crossject Introduction and Business Overview
7.10.3 PharmaJet and Crossject Intranasal Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 PharmaJet and Crossject Intranasal Vaccine Product Offerings
7.10.5 PharmaJet and Crossject Recent Development
7.11 Beijing Wantai Biopharmaceutical Co., Ltd.
7.11.1 Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
7.11.2 Beijing Wantai Biopharmaceutical Co., Ltd. Introduction and Business Overview
7.11.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Offerings
7.11.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Development
7.12 Changchun Baike Company
7.12.1 Changchun Baike Company Company Information
7.12.2 Changchun Baike Company Introduction and Business Overview
7.12.3 Changchun Baike Company Intranasal Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Changchun Baike Company Intranasal Vaccine Product Offerings
7.12.5 Changchun Baike Company Recent Development
8 Industry Chain Analysis
8.1 Intranasal Vaccine Industrial Chain
8.2 Intranasal Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Intranasal Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Intranasal Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Intranasal Vaccine Market Trends
Table 2. Intranasal Vaccine Market Drivers & Opportunity
Table 3. Intranasal Vaccine Market Challenges
Table 4. Intranasal Vaccine Market Restraints
Table 5. Global Intranasal Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Intranasal Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Intranasal Vaccine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Intranasal Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Intranasal Vaccine Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Intranasal Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Intranasal Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Intranasal Vaccine
Table 13. Global Intranasal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Intranasal Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Intranasal Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Intranasal Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Intranasal Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Intranasal Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Intranasal Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Intranasal Vaccine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Intranasal Vaccine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Intranasal Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Intranasal Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Intranasal Vaccine Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Intranasal Vaccine Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Intranasal Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Intranasal Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Intranasal Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Intranasal Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Intranasal Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Intranasal Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Intranasal Vaccine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Intranasal Vaccine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Intranasal Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Intranasal Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Intranasal Vaccine Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Intranasal Vaccine Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Intranasal Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Intranasal Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Intranasal Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Intranasal Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Intranasal Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Intranasal Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Intranasal Vaccine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Intranasal Vaccine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Intranasal Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Intranasal Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Intranasal Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Intranasal Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Intranasal Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Intranasal Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Intranasal Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Intranasal Vaccine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Intranasal Vaccine Sales Volume, (2025-2030) & (K Units)
Table 57. Sanofi Company Information
Table 58. Sanofi Introduction and Business Overview
Table 59. Sanofi Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Sanofi Intranasal Vaccine Product Offerings
Table 61. Sanofi Recent Development
Table 62. AstraZeneca Company Information
Table 63. AstraZeneca Introduction and Business Overview
Table 64. AstraZeneca Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. AstraZeneca Intranasal Vaccine Product Offerings
Table 66. AstraZeneca Recent Development
Table 67. Abbott Company Information
Table 68. Abbott Introduction and Business Overview
Table 69. Abbott Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Abbott Intranasal Vaccine Product Offerings
Table 71. Abbott Recent Development
Table 72. GlaxoSmithKline Company Information
Table 73. GlaxoSmithKline Introduction and Business Overview
Table 74. GlaxoSmithKline Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. GlaxoSmithKline Intranasal Vaccine Product Offerings
Table 76. GlaxoSmithKline Recent Development
Table 77. Serum Institute of India Company Information
Table 78. Serum Institute of India Introduction and Business Overview
Table 79. Serum Institute of India Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Serum Institute of India Intranasal Vaccine Product Offerings
Table 81. Serum Institute of India Recent Development
Table 82. Bharat Biotech Company Information
Table 83. Bharat Biotech Introduction and Business Overview
Table 84. Bharat Biotech Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Bharat Biotech Intranasal Vaccine Product Offerings
Table 86. Bharat Biotech Recent Development
Table 87. Antares Pharma Company Information
Table 88. Antares Pharma Introduction and Business Overview
Table 89. Antares Pharma Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Antares Pharma Intranasal Vaccine Product Offerings
Table 91. Antares Pharma Recent Development
Table 92. INJEX Pharma GmbH Company Information
Table 93. INJEX Pharma GmbH Introduction and Business Overview
Table 94. INJEX Pharma GmbH Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. INJEX Pharma GmbH Intranasal Vaccine Product Offerings
Table 96. INJEX Pharma GmbH Recent Development
Table 97. BioDiem Company Information
Table 98. BioDiem Introduction and Business Overview
Table 99. BioDiem Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. BioDiem Intranasal Vaccine Product Offerings
Table 101. BioDiem Recent Development
Table 102. PharmaJet and Crossject Company Information
Table 103. PharmaJet and Crossject Introduction and Business Overview
Table 104. PharmaJet and Crossject Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. PharmaJet and Crossject Intranasal Vaccine Product Offerings
Table 106. PharmaJet and Crossject Recent Development
Table 107. Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
Table 108. Beijing Wantai Biopharmaceutical Co., Ltd. Introduction and Business Overview
Table 109. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Offerings
Table 111. Beijing Wantai Biopharmaceutical Co., Ltd. Recent Development
Table 112. Changchun Baike Company Company Information
Table 113. Changchun Baike Company Introduction and Business Overview
Table 114. Changchun Baike Company Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Changchun Baike Company Intranasal Vaccine Product Offerings
Table 116. Changchun Baike Company Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Intranasal Vaccine Downstream Customers
Table 120. Intranasal Vaccine Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Intranasal Vaccine Product Picture
Figure 2. Global Intranasal Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Intranasal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Intranasal Vaccine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Intranasal Vaccine Sales Price (2019-2030) & (US$/Unit)
Figure 6. Intranasal Vaccine Report Years Considered
Figure 7. Global Intranasal Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Intranasal Vaccine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Intranasal Vaccine Revenue in 2023
Figure 10. Intranasal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Flu Vaccine Picture
Figure 12. COVID-19 Vaccines Picture
Figure 13. Global Intranasal Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Intranasal Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Intranasal Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Intranasal Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Intranasal Vaccine Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Global Intranasal Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Intranasal Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Intranasal Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Intranasal Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Intranasal Vaccine Price by Application (2019-2030) & (US$/Unit)
Figure 25. North America Intranasal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Intranasal Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Intranasal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Intranasal Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Intranasal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Intranasal Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Intranasal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Intranasal Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Intranasal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Intranasal Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Intranasal Vaccine Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Intranasal Vaccine Sales Volume (%), (2019-2030)
Figure 37. United States Intranasal Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Intranasal Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Intranasal Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Intranasal Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 43. China Intranasal Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 45. China Intranasal Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Intranasal Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Intranasal Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Intranasal Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Intranasal Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Intranasal Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Intranasal Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 55. India Intranasal Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Intranasal Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 57. India Intranasal Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 58. Intranasal Vaccine Industrial Chain
Figure 59. Intranasal Vaccine Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
